Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Clinical trial NCT05980416 · TERMINATED

Trial details

NCT number: NCT05980416
Sponsor: Elevation Oncology
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Stomach Neoplasm Gastrointestinal Neoplasms Digestive System Neoplasm Neoplasms by Site Neoplasms

Start date: 2023-08-10
Primary completion: 2025-05-07
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.